| Janice A Tawfiq, CRNA | |
|
1 Clara Maass Dr, Belleville, NJ 07109-3550 | |
| (973) 450-2000 | |
| Not Available |
| Full Name | Janice A Tawfiq |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 20 Years |
| Location | 1 Clara Maass Dr, Belleville, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174611834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 496450 (New York) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 73545 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stamford Hospital | Stamford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Anesthesiology, Pc | 1153602453 | 779 |
| Parkway Anesthesia Associates Llc | 2567758931 | 126 |
| Stamford Anesthesiology Services Pc | 9335191667 | 45 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.
In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 1 days ago
| Entity Name | Rockville Anesthesia Group, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841303997 PECOS PAC ID: 9537071873 Enrollment ID: O20031104000508 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.
In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 1 days ago
| Entity Name | North American Partners In Anesthesia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.
In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 1 days ago
| Entity Name | Physicians Of University Hospital Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417901323 PECOS PAC ID: 5890877542 Enrollment ID: O20080204000002 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.
In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 1 days ago
| Entity Name | North Shore - Lij Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417401266 PECOS PAC ID: 1153602453 Enrollment ID: O20161228001498 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.
In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janice A Tawfiq, CRNA 3100 Spring Forest Rd, Suite 130, Raleigh, NC 27616-2880 Ph: (919) 882-0706 | Janice A Tawfiq, CRNA 1 Clara Maass Dr, Belleville, NJ 07109-3550 Ph: (973) 450-2000 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.
In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 1 days ago
Mr. Johnson Fu, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Rahab Ogingo, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Mamie Jenneh Bayoh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 516-945-3000 | |
Mrs. Dianella R Sison, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 5 Franklin Ave, Suite 209, Belleville, NJ 07109 Phone: 973-751-6060 Fax: 973-450-1464 | |
Kenneth Truesdale, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 |